Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Letter to Shareholders from Patriot Scientific President/CEO Rick Goerner

No where in the news release was secondary offerings mentioned.

A CEO meets with prospective large investors to buy large blocks of stock on the open market.

This is normal activity for a CEO of a publicly traded company.



Share
New Message
Please login to post a reply